Radioligand therapy
We are making the promise of next-generation medicines a reality today by leading the development of radioligand therapies (RLTs), a novel approach to cancer care.
Molecular Imaging
At Advanced Accelerator Applications Molecular Imaging, we develop, manufacture and supply radiopharmaceutical products for positron emission tomography (PET) imaging – a cornerstone of personalized medicine.
History
Advanced Accelerator Applications was founded in 2002 by physicist Stefano Buono, who was inspired to pursue medical applications for certain research conducted during his tenure at the European Organization for Nuclear Research, or CERN, with Nobel laureate Carlo Rubbia.